Multiple inositol polyphosphate phosphatase (MIPP) is an enzyme that, in vitro, has the interesting property of degrading higher inositol polyphosphates to the Ca 2؉ second messenger, inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 ), independently of inositol lipid breakdown. We hypothesized that a truncated cytosolic form of the largely endoplasmic reticulum-confined MIPP (cyt-MIPP) could representanimportantnewtoolintheinvestigationofIns(1,4,5)P 3 -dependent intracellular Ca 2؉ homeostasis. ] i , the latter being an important modulator of Ca 2؉ signaling in the pancreatic ␤-cell.
Inositol polyphosphates have established roles in signal transduction (1) (2) (3) (4) (5) . The first inositol polyphosphate recognized to be a second messenger was inositol 1,4,5-trisphosphate (Ins(1,4,5)P 3 )
1 (1) . Ins(1,4,5)P 3 releases Ca 2ϩ from intracellular stores (6) and thus plays a central role in intracellular Ca 2ϩ homeostasis. The normal source of Ins(1,4,5)P 3 in mammalian cells is the breakdown of phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 /PIP 2 ) following the activation of G protein-or tyrosine kinase-coupled membrane receptors (1) . Interestingly, in non-mammalian cells, namely Dictyostelium, evidence has been presented that the abundant higher inositol polyphosphates, particularly Ins(1,3,4,5,6)P 5 can also be degraded to Ins(1,4,5)P 3 (7, 8) , thus separating Ins(1,4,5)P 3 production from PIP 2 breakdown and the diacylglycerol-mediated activation of protein kinase C. However, these studies did not report whether the Ins(1,4,5)P 3 so produced could impact intracellular Ca 2ϩ homeostasis. In intact mammalian cells no such pathway has been reported; however, in vitro multiple inositol polyphosphate phosphatase (MIPP) has been shown to possess the enzymatic activity to convert Ins(1,3,4,5,6)P 5 to Ins(1,4,5)P 3 via inositol tetrakisphosphate intermediates (7) . The role of this pathway in an intact cell is rather problematic because of the fact that the majority of the MIPP is confined in the ER (9, 10) and thus removed from Ins(1,3,4,5,6)P 5 , which exists largely in the cytosol (11) . There are, however, exceptions to this generalization as membrane-associated MIPP activity in human erythrocytes is exposed to the cytosol (12) . However, in general, the limited access of MIPP to its substrates restricts its use as a tool to study the impact of higher inositol polyphosphategenerated Ins(1,4,5)P 3 on [Ca 2ϩ ] i . In contrast, we reasoned that a cytosolic version of this enzyme (cyt-MIPP) may be a such a tool, allowing us to separate the production of Ins(1,4,5)P 3 from the concomitant breakdown of lipids. To best judge the impact of cyt-MIPP expression we used a ␤-cell line with an abnormally low basal intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ), reasoning that this system would represent the most sensitive assay for recording a possible impact of cyt-MIPP on [Ca 2ϩ ] i homeostasis.
We now report for the first time that cyt-MIPP expression can generate Ins(1,4,5)P 3 in an intact cell. Furthermore, it significantly impacts on cellular Ca 2ϩ homeostasis by both raising the low basal [Ca 2ϩ ] i in our model cell line to more normal levels and, as a likely consequence, considerably enhancing a previously poor Ca 2ϩ response to glucose. This enhanced response was mediated by several interlinked factors. These included the sensitizing of the ryanodine receptor (RYR) to Ca 2ϩ -induced Ca 2ϩ release (CICR) and the subsequent enhancement of Ca 2ϩ entry, predominantly through store-operated Ca 2ϩ channels. These data suggest that cyt-MIPP will be a useful tool in the investigation of Ins(1,4,5)P 3 in intracellular Ca 2ϩ homeostasis, as evidenced by 1) data suggesting a link * This work was supported by grants from Karolinska Institutet, Novo Nordisk Foundation, the National Institutes of Health (DK-58508), the Swedish Research Council, the Swedish Diabetes Association, Juvenile Diabetes Research Foundation International, Åke Wibergs Foundation, and Berth von Kantzow's Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Labeling Protocols-HIT M2.2.2. cells were routinely maintained in RPMI 1640 medium with 10% fetal bovine serum, glutamine, and penicillin/streptomycin (Invitrogen) as described previously (13) . For experiments a modified RPMI 1640, 1640-M, was used. This modified medium contained additional MgSO 4 (to give a final concentration of 0.8 mM) and 50 M inositol (to make it more representative of the physiological milieu and to enable more efficient labeling) and 5.5 mM glucose. The 10% serum in this medium had been dialyzed (1000 molecular weight cut-off; Spectro Por) to remove inositol.
HIT M2.2.2 cells were plated at about 10% of their confluent density into 35-or 92-mm dishes and allowed to grow in the above RPMI 1640-M medium for 24 h. The cells were then changed into the transfection medium, Dulbecco's modified Eagle's medium, with the same inositol concentration as the experimental RPMI 1640-M. Cyt-MIPP expression plasmid (pCI.FLAG-MIPP) or vector alone were transfected into the cells using a Ca 2ϩ phosphate precipitation technique (13) . The next day the cells were washed and reintroduced into the RPMI 1640-M medium and maintained for a further 24 h. For some experiments measuring inositol polyphosphates and [Ca 2ϩ ] i , cells were washed twice in a Krebs buffer and preincubated for 45 min in the RPMI 1640-M medium, with a reduced glucose concentration (0.1 mM). To determine cell number and approximate volume, cells were trypsinized from the dish and counted, and the volume was estimated by measuring the diameter of spherical cells with a microscope and calibrated graticule. For the measurement of inositol phosphates cells were labeled for the entire growth period of 72 h with 6 Ci/ml myo- [ 3 H]inositol (Amersham Biosciences) in the above medium in either 35-or 92-mm-diameter dishes.
Inositol Phosphate Analysis-Inositol phosphates were extracted using previously published methodologies (14 -16) . Briefly, medium was removed from the cells, and the cells were washed rapidly with KrebsRinger before addition of ice-cold 5% (w/v) trichloroacetic acid. The cell debris was pelleted, and the supernatant was removed and neutralized by ether washing and the addition of 0.1 M EDTA (pH 7.0) to bring the final pH to 6.5-7.0. To determine the mass of Ins(1,4,5)P 3 a commercial binding protein assay was used (Amersham Biosciences). The assay was carried out exactly as described in the supplied manual using a perchloric acid extraction protocol. Samples were then stored at Ϫ20°C until required for HPLC.
HPLC-We performed HPLC on a 25-cm Whatman Partisphere-SAX column (Laserchrom, United Kingdom). For InsP separations HPLC was carried out as described previously (16) . Initial identification of InsP species was carried out by the inclusion of [ 3 H]inositol phosphate standards: inositol 1-phosphate, inositol 1,4-bisphosphate, inositol 1,3,4-trisphosphate, Ins(1,4,5)P 3 , Ins(1,3,4,5)P 4 , and InsP 6 in samples split into two. The two halves were run with and without standards. Standards were obtained from PerkinElmer Life Sciences, with the exception of inositol 1,3,4 trisphosphate, which was prepared from the Ins(1,3,4,5)P 4 by dephosphorylation using human erythrocyte membranes. Other inositol phosphates were identified by their relative elution positions and comparison of a previous study (16) on ␤-cells using [
14 C]-labeled internal standards and identical elution conditions. Actual concentrations of InsPs were estimated based on the known volume of the cells and the known specific activity of the inositol used to label the majority of the cellular material. Radioactivity was determined by the addition of Packard Ultima Flo AP scintillant and counting on a Packard CA 2000 scintillation counter (both from CIAB, Stockholm, Sweden).
Measurement of [Ca 2ϩ ] i -Cells were cultured and transfected as above. They were then preincubated in basal glucose (0.1 mM) for 45 min. At the beginning of this preincubation period cells were loaded with Fura-2/AM to give a final concentration of 2 M. Transfected cells were identified by DsRed (Molecular Probes, Leiden, Netherlands) fluorescence following coexpression with pRcCMVi.DsRed. DsRed was used rather than GFP because of the substantial interference of GFP in Fura-2 measurements, whereas DsRed has little impact. Fluorescence imaging was performed with a cool charged-coupled device camera (CH250 with KAF 1400; Photometrics, Tucson, AZ) connected to an imaging system (Inovision, Durham, NC) placed on a Zeiss Axiovert 135TV microscope (Carl Zeiss AGT, Göttingen, Germany) with a 515/40 emission filter using the Ratiotool software (Inovision). A SPEX fluorolog-2 CMlT11I spectrofluorimeter (SPEX industries, Edison, NJ) was used for fluorescence excitation at 340 and 380 nm. [Ca 2ϩ ] i was expressed as the ratio of fluorescence at 340 and 380 nm. To estimate basal [Ca 2ϩ ] i in the MIPP-versus mock-transfected cells, the experiments were calibrated as described previously (17 
RESULTS
The construct used in this study was based on the N-terminal truncated rat MIPP sequence first reported by Craxton et al. (10) . This sequence lacks the signal peptide necessary for translocation into the ER and was used to degrade cytosolic inositol polyphosphates. Although our cyt-MIPP had no ER signal peptide, recent reports have suggested that other internal peptide sequences can confer ER targeting (18) . Furthermore, the only other published study using a truncated MIPP (19) had both the signal peptide and the ER retention sequence removed, whereas in the current study the construct still had the ER retention sequence. To verify that the cyt-MIPP was indeed cytosolic and not ER-localized, a cyt-MIPP bearing a GFP tag was expressed in HIT M2.2.2 cells. Examination with confocal microscopy discerned that GFP-cyt-MIPP was present throughout the cytosol. There was no co-localization with the fluorescent ER marker Brefeldin A, BODYiPY 558/568 conjugate, Molecular Probes (data not shown). Our experience (20) , along with the experience of many others (21) , is that a GFP tag itself does not present a restriction for the entry of peptides into the ER.
Changes in Inositol Polyphosphate Profile following cyt-MIPP Expression-In our initial experiments we established that cyt-MIPP expression decreased the concentration of its principal substrates, Ins(1,3,4,5,6)P 5 and InsP 6 . Note, however, that only 30% of the cells were transfected (data not shown), so changes in concentration of inositol polyphosphates in a single cyt-MIPP-transfected cell were considerably underestimated because of the dilution with non-transfected cells. Fig. 1A indicates a significant 25% reduction in the concentrations of both Ins(1,3,4,5,6)P 5 and InsP 6 after cyt-MIPP expression.
Next we wanted to assess the downstream products of Ins(1,3,4,5,6)P 5 and InsP 6 degradation. To enable us to detect changes in Ins(1,4,5)P 3 resulting from cyt-MIPP transfection, we insured that little Ins(1,4,5)P 3 was being generated from PtdIns(4,5)P 2 by preincubating the cells for 45 min in medium with low glucose (0.1 mM) thereby creating a basal state. All subsequent data (unless stated otherwise) were obtained from cells preincubated in this manner. Fig. 2 presents a scheme depicting the putative products of cyt-MIPP-catalyzed metabolism of Ins(1,3,4,5,6)P 5 and InsP 6 . There were significant increases in Ins(1,2,3)P 3 (20%) and in peaks with the elution characteristics of D/L-Ins(1,4,6)P 3 (56%) and Ins(1,3,4,5)P 4 (79%) in cyt-MIPP-compared with mocktransfected cells, (data not shown). However, it is important to note that the concentrations of these inositol polyphosphates were initially so low (ϳ0.2 M) that even an increased production is unlikely to have any cellular impact. These inositol polyphosphates could all be derived directly or indirectly from cyt-MIPP degradation of Ins(1,3,4,5,6)P 5 and InsP 6 (see Fig. 2 ). The shape of the mock-but not the cyt-MIPP-transfected Ins(1,4,5)P 3 peak was skewed (data not shown), indicating that more than one InsP 3 isomer was present in the peak. The fact that only the mock-transfected Ins(1,4,5)P 3 peak was skewed suggests that this contaminant did not go up after cyt-MIPP transfection. Noteworthy is that the contribution of the contaminant to the Ins(1,4,5)P 3 signal in the mock-transfected cells reduced our ability to detect an increase in genuine Ins(1,4,5)P 3 against a high non-Ins(1,4,5)P 3 background. In a previous study in normal mouse ␤-cells, the peak of Ins(1,4,5)P 3 (14) also indicated contamination from an unknown InsP 3 , which masked bona fide Ins(1,4,5)P 3 . Thus, we used a commercial mass assay, specific for D-myo-Ins(1,4,5)P 3 , to determine the true increase in Ins(1,4,5)P 3 . We estimated that approximately half of the HPLC-resolved Ins(1,4,5)P 3 was another InsP 3 . Fig. 1B illustrates a significant 36% increase in Ins(1,4,5)P 3 concentration between cyt-MIPP-and mock-transfected cells, when only genuine Ins(1,4,5)P 3 was measured. It is important to note that because of the 30% transfection rate (see above) the actual rise in concentration of Ins(1,4,5)P 3 in a transfected cell would be considerably greater, about double the concentration in the mock-transfected cells. Thus cyt-MIPP expression significantly enhanced basal Ins(1,4,5)P 3 concentration in intact cells and not just in vitro as has been reported previously (7) .
Effect responses of cyt-MIPPtransfected cells were considerably greater in amplitude and duration than the responses for the mock-transfected cells, which were rather feeble. Moreover, the pattern of multiple peaks in cyt-MIPP-transfected cells was not discerned in the mock-transfected cells. This pattern of multiple peaks has also been recorded in ␤-cell studies in which the RYR was sensitized (22) and are thought to be representative of CICR. These data suggest that cyt-MIPP transfection was able to dramatically enhance the glucose-stimulated rise in [Ca 2ϩ ] i in this previously poorly responsive insulin-secreting cell line. Thus it was important to understand the mechanism of this transformation in greater depth.
In normal pancreatic ␤-cells the dominant mechanism whereby glucose raises [Ca 2ϩ ] i is thought to be through the opening of voltage-dependent L-type Ca 2ϩ channels (23) . To establish whether L-type Ca 2ϩ channels were involved in the improved response in cyt-MIPP-expressing cells, we pretreated 3 H]inositol (6 Ci/ml). Cells were then either immediately acid-killed (A) or preincubated for 45 min in RPMI 1640-M (see "Experimental Procedures") with basal glucose (0.1 mM) and then acid-killed (B). The InsPs were extracted and then separated using inositol phosphate HPLC protocol, and the radioactivity was determined (see "Experimental Procedures"). A, the concentrations of Ins(1,3,4,5,6)P 5 and InsP 6 are plotted from cyt-MIPP-transfected cells relative to mock-transfected cells with appropriate adjustments for differences in cell volume and number. The data are the mean Ϯ S.E. of five separate experiments each carried out in triplicate. *, p Ͻ 0.05 (unpaired t test). B, D-Ins(1,4,5)P 3 was determined in mock-versus cyt-MIPP-transfected cells using a commercial kit. cyt-MIPP-transfected data are presented as percent of mock-transfected cells with adjustments made for differences in cell volume and number. The data shows the mean Ϯ S.E. from three separate experiments each carried out in triplicate. Significance was carried out using an unpaired Student's t test; **, p Ͻ 0.01.
the cells with the specific L-type Ca 2ϩ channel blocker nimodipine and then stimulated with glucose. Fig. 4B (24) . An increased emptying of intracellular stores is likely following cyt-MIPP expression because of raised levels of Ins(1,4,5)P 3 . The subsequent increase in basal [Ca 2ϩ ] i may enhance Ca 2ϩ release from both Ins(1,4,5)P 3 -and ryanodine (RY)-sensitive stores, respectively. We therefore used pharmacological agents to ascertain the nature of the stores involved in mock-and cyt-MIPP-transfected HIT M2.2.2 cells. Fig. 6A shows cells preincubated with the Ins(1,4,5)P 3 receptor blocker 2-aminoethoxydiphenyl-borate (2-APB) and then stimulated with glucose. 2-APB completely blocked the glucoseinduced rise in [Ca 2ϩ ] i in both mock-and cyt-MIPP-transfected cells (cf. Fig 4A) . During the blockade of the Ins(1,4,5)P 3 -sensitive stores it should still be possible to measure Ca 2ϩ entry through L-type Ca 2ϩ channels by depolarizing the cells with KCl. Addition of KCl, together with glucose or on its own, resulted in a distinct but small change in [Ca 2ϩ ] i . This confirms the nimodipine data that suggested that the L-type channel only made a small contribution to the overall [Ca 2ϩ ] i increase and raises the notion that this ␤-cell variant has a low number of functional L-type Ca 2ϩ channels. Recent data have indicated that 2-APB has additional effects on capacitative Ca 2ϩ entry (reviewed in Ref. 25) . It has been reported to inhibit storeoperated Ca 2ϩ entry at a lower concentration than required to block the Ins(1,4,5)P 3 -receptor (25) . Thus a block by 2-APB of the Ins(1,4,5)P 3 receptor will always be accompanied by an effective inhibition of capacitative Ca 2ϩ entry. Therefore, we checked our conclusions regarding the cyt-MIPP-expressing cells by the use of an alternative cell-permeant Ins(1,4,5)P 3 receptor blocker, Xestospongin C. Xestospongin C was also able to block the glucose-mediated increase in [Ca 2ϩ ] i (Fig. 6B versus Fig. 4A ), though the effect was not as complete as with 2-APB (Fig. 6, B versus A) , which suggests that capacitative Ca 2ϩ entry may be involved in the enhanced glucose-induced Ca 2ϩ response. We next examined the role of RY-sensitive stores, suggested previously (22) to have an important role in ␤-cell CICR mechanisms. RY-sensitive stores can be blocked by high concentrations of RY but only when the receptor is in the open form. Thus we used the combination of caffeine to open the receptor and a high concentration of RY to block it. In ␤-cells caffeine does not significantly impact the Ins(1,4,5)P 3 -sensitive stores (26) . Fig.  6C demonstrates that blockade of the RYR dramatically reduced the Ca 2ϩ response of mock-and cyt-MIPP-transfected cells (Fig. 6C versus Fig. 4A ). Again K ϩ depolarization alone revealed a small component of [Ca 2ϩ ] i increase dependent on the entry of Ca 2ϩ through L-type Ca 2ϩ channels. Summarizing the data from the pharmacological studies above, it is clear that the full glucose-induced Ca 2ϩ response can only be partially blocked by a the Ins(1,4,5)P 3 receptor antagonist Xestospongin C. This is the antagonist whose actions are not complicated by effects on Ca 2ϩ entry. However, blockade of the RYR virtually abolished the glucose-induced Ca 2ϩ -response. Thus, although Ca 2ϩ release from Ins(1,4,5)P 3 -sensitive stores can contribute to the overall Ca 2ϩ rise, without the operation of the RYRsensitive Ca 2ϩ stores, this Ca 2ϩ mobilization is ineffective in promoting the glucose-stimulated rise in [Ca 2ϩ ] i . The above data suggest that cyt-MIPP enables the coupling between glucose metabolism and the release of Ca 2ϩ from intracellular stores. This mechanism was apparently defective in the parent HIT M2.2.2 cell. One possible explanation for the difference between mock-and cyt-MIPP-transfected cells could be the Ca 2ϩ content of the stores themselves. Therefore we assessed the content of the stores by adding the store Ca 2ϩ -ATPase inhibitor thapsigargin (Tg) (Fig. 7) . Fig. 7 indicates that application of Tg releases Ca 2ϩ from intracellular stores of both mock-and MIPP-transfected cells; however, the cyt-MIPP-transfected cells had a lower amount of Ca 2ϩ in the stores. Fig. 7 (7) . However, in many cells MIPP is confined in the ER with a limited access to Ins(1,3,4,5,6)P 5 , and thus in these cells MIPP is likely to have a limited impact on cellular Ca 2ϩ homeostasis. Our hypothesis was that a truncated form of the MIPP (cyt-MIPP) normally expressed in the cytosol might serve as an important general tool in the investigation of Ins(1,4,5)P 3-dependent Ca 2ϩ homeostasis independently of receptor-activated inositol lipid breakdown. If this hypothesis is to be verified we need to demonstrate both that Ins(1,4,5)P 3 can be generated from higher inositol polyphosphates in an intact cell and that this generated Ins(1,4,5)P 3 could make an impact on [Ca 2ϩ ] i . We also needed to be sure that other potential by-products of MIPP activity are not likely to be significant contributors to both Ca 2ϩ homeostasis and cell physiology in general. To this end we used a cell line with an abnormally low basal [ (1,3,4 ,5,6)P 5 and InsP 6 . In this respect, the 25% reduction in both Ins (1,3,4 therefore not surprising. Because about one-third of the cells were transfected the impact in an individual cell would be considerably greater than this. These data are also consistent with the one other published report (19) documenting the expression of a cytosolic version of MIPP. In this latter case, an even greater reduction in Ins(1,3,4,5,6)P 5 and InsP 6 was observed (57 and 40%, respectively; see Ref. 19) . This difference is likely to be a reflection of the different levels of expression of cyt-MIPP in the two cell systems. n ϭ 9) . E, summary graph of the change in open probability shows that cells expressing cyt-MIPP (n ϭ 9) display significantly higher open probability than control cells (n ϭ 9; *, p Ͻ 0.05). F, summary graph of the change in availability shows that cells expressing cyt-MIPP (n ϭ 9) display significantly higher availability than control cells (n ϭ 9; *, p Ͻ 0.05). Data are presented as means Ϯ S.E. Statistical significance was evaluated by unpaired Student's t test. stores. Cells were prepared as described in Fig. 4 . A, cells were preincubated with 100 M 2-APB and then stimulated with 16.7 mM glucose or KCl at the times indicated. B, cells were preincubated with 20 M Xestospongin C and then stimulated with glucose as indicated. C, cells were preincubated with a mixture of 5 mM caffeine and 100 M ryanodine, to block ryanodine sensitive Ca 2ϩ stores. The traces are representative of 10 other experiments. D/L-Ins(1,4,6)P 3 is a putative inositol 1,3,4,6-tetratrisphosphate metabolite (see Fig. 2 and Ref. 27). Both inositol 1,3,4,6-tetratrisphosphate and Ins(1,3,4,5)P 4 can be derived by the action of MIPP on Ins(1,3,4,5,6)P 5 (see Fig. 2 and Ref. 7) . However, Ins(1,3,4,5)P 4 can also be produced by the action of the Ca 2ϩ -activated Ins(1,4,5)P 3 3Ј-kinase on Ins(1,4,5)P 3 (Fig. 2) . It is worth reinforcing at this time that the relatively small increase in Ins(1,4,5)P 3 (Ϸ35%) will be an underestimate because of the 30% transfection rate. Thus in a single transfected cell the actual Ins(1,4,5)P 3 concentration would be doubled by cyt-MIPP. This is important to note when marrying the Ins(1,4,5)P 3 changes with the [Ca 2ϩ ] i changes discussed below. The usefulness of cyt-MIPP as a tool is dependent on whether other products of MIPP activation, besides Ins(1,4,5)P 3 , have an impact on cell Ca 2ϩ homeostasis or on general cellular physiology. However, at the outset it is important to note that these other inositol polyphosphates exist at low concentrations, and their increase upon MIPP expression is relatively small. The inositol polyphosphates with detectable increases that also may impact on Ca 2ϩ handling are D/LIns(1,4,6)P 3 (28, 29) and Ins(1,3,4,5)P 4 (30, 31) . D/L-Ins(1,4,6)P 3 is a partial agonist of the Ins(1,4,5)P 3 receptor with the Disoform being the most potent and thus relevant enantiomer (29) . We estimate the increase in this mixed peak in a single transfected cells to be maximally 0.17 M over basal concentrations, in contrast to an increase in Ins(1,4,5)P 3 concentration of 0.7 M over basal concentrations. The combination of the 4-fold higher concentration of Ins(1,4,5)P 3 allied with the 3-80-fold lower potency of D-Ins(1,4,6)P 3 (28, 29) , dependent on Ins(1,4,5)P 3 receptor subtype (29) , suggests that the contribution of D-Ins(1,4,6)P 3 will be negligible, especially in cells in which the type 2 or type 3 receptors dominate (29) , which includes ␤-cells. Ins(1,3,4,5)P 4 also has a role in Ca 2ϩ homeostasis, aiding Ins(1,4,5)P 3 -induced capacitative Ca 2ϩ entry (30, 31) . However, Ins(1,3,4,5)P 4 is only a minor product of MIPP action (see Ref. 7 and Fig. 2) , and the most likely source of Ins(1,3,4,5)P 4 in the current experiments is the Ins(1,4,5)P 3 derived directly from cyt-MIPP activity and not from higher inositol polyphosphates (see above). Nonetheless, we estimate the maximal concentration of Ins(1,3,4,5)P 4 to be 0.4 M in contrast to 2 M, the minimally effective concentration of Ins(1,3,4,5)P 4 required to enhance capacitative Ca 2ϩ entry (30) . The only other inositol phosphate to increase in concentration is the Ins(1,2,3)P 3 , which is ineffective as an agonist to the Ins(1,4,5)P 3 receptor (28). Ins(1,2,3)P 3 is an iron chelator and proposed iron shuttle (16) . Could the very small increase in Ins(1,2,3)P 3 impact on intracellular iron metabolism? This is not a likely scenario, because Ins(1,2,3)P 3 has related properties to the iron chelator desferrioxamine but is less potent. In this context desferrioxamine is required at a 500-fold higher concentration than the actual Ins(1,2,3)P 3 concentration obtained subsequent to MIPP expression to elicit any impact on cellular iron metabolism (32) . Thus cyt-MIPP is able to generate Ins(4,5)P 3 independently of PtdIns(1,4,5)P 2 breakdown without serious interference from other inositol phosphate products. It is interesting to note that raising Ins(1,4,5)P 3 by an alternative strategy, namely the knock-down of the Ins(1,4,5)P 3 /Ins(1,3,4,5)P 4 5-phosphatase produced results similar to those described in the current work (33) (34) (35) .
These data indicate for the first time that Ins(1,4,5)P 3 can be generated in the intact cell following cyt-MIPP expression. The fact that Ins(1,4,5)P 3 can be derived from higher inositol polyphosphates, principally Ins(1,3,4,5,6)P 5 , has previously only been shown in a non-mammalian cell, Dictyostelium (7, 8) , although the identity of the enzyme responsible remains unknown. Full-length MIPP is confined in the ER in a number of cell types (9, 19) and thus separated from its principal substrates. However, studies on human erythrocytes have suggested that MIPP activity is associated with the inner leaflet of plasma membranes and thus with easy access to its principal substrates (12) . This suggests that, in at least some mammalian cells, a pathway exists that makes the generation of Ins(1,4,5)P 3 independent of lipid breakdown a real physiological possibility.
Impact (36, 37) . This is because a number of contributing factors, in addition to Ins(1,4,5)P 3 concentration, can play a role in setting basal [Ca 2ϩ ] i , in particular plasma membrane and ER Ca 2ϩ -ATPases and various plasma membrane Ca 2ϩ channels (36) . Also, the mechanism of Ins(1,4,5)P 3 action is normally associated with an acute rise and fall in [Ca 2ϩ ] i , characteristic of its second messenger function (1). Nonetheless, it is interesting to note that this is the third study that we are aware of that has correlated Ins(1,4,5)P 3 found in the cells with reduced Ins(1,4,5)P 3 /Ins(1,3,4,5)P 4 5-phosphatase activity was still largely maintained in the absence of extracellular Ca 2ϩ (33 (39) and the subsequent enhancement of the protein kinase A phosphorylation of the channel that results in its increased activity (40) . Fig. 5 indicates that there are significant increases in open probability and channel availability following cyt-MIPP expression. These particular changes in channel characteristics specifically relate to increased phosphorylation of this channel by protein kinase A (40) (see above). Thus there is a clear mechanism linking the raised basal [Ca 2ϩ ] i created by cyt-MIPP expression and the observed enhancement of L-type Ca 2ϩ channel activity. However, the improved response did not come primarily from this enhancement of the L-type Ca 2ϩ channel activity (23) , because the specific L-type Ca 2ϩ channel blocker nimodipine only reduced the enhanced response by about 20% (see Fig. 4B ). Therefore, the Ca 2ϩ sensitivity of the intracellular Ca 2ϩ stores is likely to be the more important player in the restored glucose-induced Ca 2ϩ response. In normal insulin-secreting ␤-cells, the L-type Ca 2ϩ channel has a partner, the RY-sensitive intracellular Ca 2ϩ store (22, 38) . It is now better appreciated that, like in cardiac cells, in ␤-cells the Ca 2ϩ entering the cell via the L-type Ca 2ϩ channel triggers CICR from the RYR-operated intracellular Ca 2ϩ stores (22, 38 ] i observed upon glucose stimulation. These multiple peaks are a common observation in glucose-stimulated ␤-cells (38) , but their magnitude is often small. However, sensitization of the RYR reveals a strikingly regular repetitive Ca 2ϩ spiking pattern of greater amplitude thought to be associated with CICR (22, 38, 41) . More directly, our data clearly show that blockade of the RYR prevents the enhanced Ca 2ϩ response to glucose in cyt-MIPP cells, confirming this idea. Our discussions above indicate that in the case of the HIT M2.2.2 cells the majority of the Ca 2ϩ trigger for CICR is not coming from the L-type channel, which suggests other intracellular Ca 2ϩ stores, possibly those sensitive to Ins(1,4,5)P 3 , are responsible for the initiation of the CICR. Glucose can stimulate increased levels of Ins(1,4,5)P 3 in ␤-cells leading to the mobilization of intracellular Ca 2ϩ (42) . Our data support the idea that this mechanism contributes to the enhanced glucose response as the blockade of the Ins(1,4,5)P 3 receptor can completely or partially block the response, dependent on the pharmacological agent used, 2-APB or Xestospongin C, respectively. Because 2-APB is a better blocker of store-operated capacitative Ca 2ϩ entry than it is of the Ins(1,4,5)P 3 receptor (25), the partial block afforded by the Xestospongin is probably more relevant. Thus Ca 2ϩ released from Ins(1,4,5)P 3 -sensitive stores is an important contributor to the proposed Ca 2ϩ activation of the RYR. Glucose can also stimulate RYR operation in other ways. One is the direct priming by the glycolytic intermediate fructose 1,6-bisphosphate (43) and another is the phosphorylation of the channel by protein kinase A (44) whose activity, we have already argued, is enhanced by raised [Ca 2ϩ ] i (see above). One other important final element needs to be integrated into this model. The fact that both the omission of extracellular Ca 2ϩ (Fig. 4C ) and the application of 2-APB (an inhibitor of capacitative Ca 2ϩ entry (Fig. 6A ) (see above)) can completely block the response, suggests that store-operated Ca 2ϩ entry plays an important role (24) . Hence, the apparent depletion of the intracellular stores in cyt-MIPP-expressing cells (Fig. 7 ) may act to enhance capacitative Ca 2ϩ entry as the stores will require less Ca 2ϩ released from them to reach the threshold needed for storeoperated Ca 2ϩ influx to be activated. In short, we hypothesize that the primary consequence of the raised basal [Ca 2ϩ ] i is to prime the RYR to Ca 2ϩ . The RYR can then be activated by glucose metabolism and the glucose-induced increase in [Ca 2ϩ ] i coming largely from Ins(1,4,5)P 3 -sensitive stores.
We have shown that expression of cyt-MIPP can raise Ins(1,4,5)P 3 concentration in an insulin-secreting cell, without a significant contribution of other cyt-MIPP side products. The raised Ins(1,4,5)P 3 has an impact on basal [Ca 2ϩ ] i , raising a previously low [Ca 2ϩ ] i to a more physiological basal concentration. This increase in basal [Ca 2ϩ ] i is mechanistically linked to the dramatically enhanced glucose-stimulated [Ca 2ϩ ] i seen following cyt-MIPP expression. These data support the use of cyt-MIPP as an important tool in investigating Ins(1,4,5)P 3 -dependent Ca 2ϩ homeostasis and the idea of a close link between basal Ins(1,4,5)P 3 concentration and basal [Ca 2ϩ ] i , the latter being an important modulator of Ca 2ϩ signaling in the pancreatic ␤-cell.
